About - CrossBridge
CrossBridge is on a mission to help achieve the best outcomes at the lowest possible cost for all chronic inflammatory and autoimmune disease. CrossBridge resulted from the vision of Bill Conlan, who has deep experience in the application of the latest technologies to meet challenges in healthcare. Bill’s resolve to attack chronic inflammatory disease comes from his own experience with ankylosing spondylitis.
Bill Conlan, Susan Spalding, Bruce Freundlich MD
13822
page-template,page-template-full_width,page-template-full_width-php,page,page-id-13822,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

About

Your Mission Is Our Mission: To Achieve the
Best Outcomes at the Lowest Cost.

Bill Conlan

Chief Executive Officer

Bill has 25 years-experience as an entrepreneur with a history of employing the latest technologies to meet challenges in health care. Most recently, Bill co-founded HealthQx, a value-based payment analytics company relied on by payers with 65 million total members. HealthQx was acquired by McKesson in 2016, and renamed Change Healthcare. Previously, Bill founded Healthcare Data Management (HDM), a pioneer in modeling employee health benefit plans and using data-driven metrics to monitor health plan spend. HDM was acquired by Thomson Reuters in 2010 and is now part of IBM Watson. CrossBridge is a mission for Bill, who has ankylosing spondylitis. He also has family members with rheumatoid arthritis and multiple sclerosis

Bruce Freundlich, MD

Chief Medical Officer

Bruce is skilled in clinical research and medical affairs, with expertise in Rheumatology, Dermatology, Endocrinology and Neuro-psychiatry. Dr. Freundlich was Senior Vice president, Medical at Antares Pharmaceuticals and Vice President Inflammation and Vice President, Global Medical Affairs at Pfizer Pharmaceuticals over a nine-year period. Among other accomplishments, he was responsible for bringing Enbrel to market. Dr. Freundlich also served as Chief of Clinical Rheumatology at the University of Pennsylvania for more than six years. Professor of Medicine and alumnus, University of Pennsylvania. MBA at University Massachusetts, Amherst.

Larry De Lutiis Jr

Chief Technology Officer

Larry brings more than 20 years of experience leading the delivery of high-impact technology, M&A integration, and global service solutions. Larry has held several senior technology roles and has spent the better part of the last ten years at Kenexa Technologies where he acted as their Vice President of IT through their global expansion and acquisition to IBM. Throughout Larry’s career, he has provided strategic vision and leadership for developing and implementing information technology initiatives that aligned with aggressive growth strategies.

Desislava Prodanova

VP Product Development

Desislava is responsible for driving development of the CrossBridge product and implementing product strategy across the full software life cycle.  Desislava has over 20 years experience in product management and development with a focus on healthcare IT. She has successfully planned, defined and led the implementation of complex integration solutions for HealthQx, SAP, InterComponentWare.  She leads a cross-functional product team to develop detailed product plans including technology development and roll-out strategy, to ensure products meets market needs. Desislava earned a M.Sci. Business Informatics, Georg-August-University, Germany and M.Sci. International Economics, University of National & World Economics, Bulgaria.